| scholarly article | Q13442814 |
| P50 | author | Gene L Bidwell | Q59162472 |
| P2093 | author name string | Angela A Whittom | |
| Michael D Hebert | |||
| Drazen Raucher | |||
| Daniel Lyons | |||
| Emily Thomas | |||
| P2860 | cites work | Development of elastin-like polypeptide for thermally targeted delivery of doxorubicin. | Q40197844 |
| Tumor accumulation, degradation and pharmacokinetics of elastin-like polypeptides in nude mice | Q40242004 | ||
| Enhancing the antiproliferative effect of topoisomerase II inhibitors using a polypeptide inhibitor of c-Myc | Q40346171 | ||
| Evaluation of cell penetrating peptides fused to elastin-like polypeptide for drug delivery | Q40374638 | ||
| Application of thermally responsive polypeptides directed against c-Myc transcriptional function for cancer therapy. | Q40397492 | ||
| Pladienolides, new substances from culture of Streptomyces platensis Mer-11107. III. In vitro and in vivo antitumor activities | Q40554037 | ||
| Biological methylation of myelin basic protein: enzymology and biological significance | Q41557734 | ||
| Arginine methylation regulates IL-2 gene expression: a role for protein arginine methyltransferase 5 (PRMT5). | Q41927743 | ||
| The emerging role of splicing factors in cancer | Q43244074 | ||
| A proteomic analysis of arginine-methylated protein complexes | Q44611061 | ||
| Splicing factor SF3b as a target of the antitumor natural product pladienolide. | Q50672786 | ||
| Tracking the in vivo fate of recombinant polypeptides by isotopic labeling. | Q50745066 | ||
| Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. | Q55474541 | ||
| PRMT5 (Janus Kinase-binding Protein 1) Catalyzes the Formation of Symmetric Dimethylarginine Residues in Proteins | Q56227906 | ||
| Pharmacodynamic aspects of peptide administration biological response modifiers | Q73850407 | ||
| Endogenous IL-2 in cancer cells: a marker of cellular proliferation | Q74486185 | ||
| Thermally targeted delivery of chemotherapeutics and anti-cancer peptides by elastin-like polypeptide | Q80816543 | ||
| Interactions between coilin and PIASy partially link Cajal bodies to PML bodies | Q81340853 | ||
| PRMT7, a new protein arginine methyltransferase that synthesizes symmetric dimethylarginine | Q24307732 | ||
| Two distinct arginine methyltransferases are required for biogenesis of Sm-class ribonucleoproteins | Q24337867 | ||
| Symmetrical dimethylation of arginine residues in spliceosomal Sm protein B/B' and the Sm-like protein LSm4, and their interaction with the SMN protein. | Q24540057 | ||
| The methylosome, a 20S complex containing JBP1 and pICln, produces dimethylarginine-modified Sm proteins | Q24548244 | ||
| Human SWI/SNF-associated PRMT5 methylates histone H3 arginine 8 and negatively regulates expression of ST7 and NM23 tumor suppressor genes | Q24563451 | ||
| The human homologue of the yeast proteins Skb1 and Hsl7p interacts with Jak kinases and contains protein methyltransferase activity | Q27931859 | ||
| Hsl7p, the yeast homologue of human JBP1, is a protein methyltransferase | Q27932318 | ||
| Arginine methylation regulates the p53 response | Q28116284 | ||
| The C-terminal RG dipeptide repeats of the spliceosomal Sm proteins D1 and D3 contain symmetrical dimethylarginines, which form a major B-cell epitope for anti-Sm autoantibodies | Q28140527 | ||
| Methylation of SPT5 Regulates Its Interaction with RNA Polymerase II and Transcriptional Elongation Properties | Q28201556 | ||
| Understanding alternative splicing: towards a cellular code | Q29615085 | ||
| Symmetrical dimethylarginine methylation is required for the localization of SMN in Cajal bodies and pre-mRNA splicing. | Q31121644 | ||
| Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors | Q33283850 | ||
| New advances in the transport of doxorubicin through the blood-brain barrier by a peptide vector-mediated strategy. | Q33895267 | ||
| Transmembrane transport of peptide type compounds: prospects for oral delivery | Q34358500 | ||
| Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors | Q35088660 | ||
| Incorporation of 5-fluorouracil into U2 snRNA blocks pseudouridylation and pre-mRNA splicing in vivo | Q35646810 | ||
| Free energy transduction in polypeptides and proteins based on inverse temperature transitions | Q35924393 | ||
| The gene encoding the splicing factor SF2/ASF is a proto-oncogene | Q36129226 | ||
| Molecular functions of the SMN complex | Q36924730 | ||
| The spliceosome as target for anticancer treatment | Q37335031 | ||
| Treatment of metastatic renal cell carcinoma | Q37431682 | ||
| Inhibition of ovarian cancer cell proliferation by a cell cycle inhibitory peptide fused to a thermally responsive polypeptide carrier | Q37480921 | ||
| Therapeutic peptides for cancer therapy. Part I - peptide inhibitors of signal transduction cascades. | Q37564522 | ||
| Therapeutic peptides for cancer therapy. Part II - cell cycle inhibitory peptides and apoptosis-inducing peptides | Q37594770 | ||
| Control of the DNA methylation system component MBD2 by protein arginine methylation | Q38411717 | ||
| Application of thermally responsive elastin-like polypeptide fused to a lactoferrin-derived peptide for treatment of pancreatic cancer. | Q39840364 | ||
| Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptides. | Q39903725 | ||
| Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. | Q40104313 | ||
| A thermally targeted elastin-like polypeptide-doxorubicin conjugate overcomes drug resistance. | Q40136335 | ||
| P433 | issue | 5 | |
| P1104 | number of pages | 8 | |
| P304 | page(s) | 834-841 | |
| P577 | publication date | 2010-02-16 | |
| P1433 | published in | Peptides | Q7166533 |
| P1476 | title | A thermally targeted peptide inhibitor of symmetrical dimethylation inhibits cancer-cell proliferation | |
| P478 | volume | 31 |
| Q38804663 | A kidney-selective biopolymer for targeted drug delivery. |
| Q34490667 | A polypeptide drug carrier for maternal delivery and prevention of fetal exposure. |
| Q39645455 | A thermally responsive biopolymer conjugated to an acid-sensitive derivative of paclitaxel stabilizes microtubules, arrests cell cycle, and induces apoptosis |
| Q36344276 | Anticancer activity of proapoptotic peptides is highly improved by thermal targeting using elastin-like polypeptides |
| Q38224685 | Applications of elastin-like polypeptides in drug delivery. |
| Q34291585 | Cell penetrating peptides fused to a thermally targeted biopolymer drug carrier improve the delivery and antitumor efficacy of an acid-sensitive doxorubicin derivative |
| Q38558102 | Challenges and new strategies for therapeutic peptide delivery to the CNS. |
| Q38152205 | Designing protein-based biomaterials for medical applications |
| Q38263314 | Elastin-like polypeptide for improved drug delivery for anticancer therapy: preclinical studies and future applications |
| Q37914083 | Elastomeric polypeptides |
| Q34353772 | Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer |
| Q35047445 | Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis |
| Q55039164 | Molecular Size Modulates Pharmacokinetics, Biodistribution, and Renal Deposition of the Drug Delivery Biopolymer Elastin-like Polypeptide. |
| Q38214156 | Penetrating the cell membrane, thermal targeting and novel anticancer drugs: the development of thermally targeted, elastin-like polypeptide cancer therapeutics |
| Q34553438 | Protein-engineered biomaterials: nanoscale mimics of the extracellular matrix |
| Q36824532 | Structural and hydrodynamic analysis of a novel drug delivery vector: ELP[V5G3A2-150]. |
| Q43523795 | The design and delivery of a PKA inhibitory polypeptide to treat SCA1. |
| Q30460371 | The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration |
| Q36083695 | Thermal targeting of an acid-sensitive doxorubicin conjugate of elastin-like polypeptide enhances the therapeutic efficacy compared with the parent compound in vivo |
| Q30458838 | Thermally targeted delivery of a c-Myc inhibitory polypeptide inhibits tumor progression and extends survival in a rat glioma model |
| Q50014994 | VEGF therapy for the kidney: emerging strategies. |
Search more.